Get the Stockscreener App
18.01
0.06%
0.01
After Hours:
18.01
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $18.01, with a volume of 1.12M.
It is up +0.06% in the last 24 hours and down -0.72% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
See More
Previous Close:
$18.00
Open:
$17.98
24h Volume:
1.12M
Relative Volume:
2.90
Market Cap:
$792.59M
Revenue:
$159.01M
Net Income/Loss:
$-21.72M
P/E Ratio:
-34.63
EPS:
-0.52
Net Cash Flow:
$-20.63M
1W Performance:
-0.66%
1M Performance:
-0.72%
6M Performance:
+43.85%
1Y Performance:
+73.67%
1-Day Range:
$17.10
$18.61
1-Week Range:
$17.10
$19.19
52-Week Range:
$5.55
$19.19
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
18.01 | 792.59M | 159.01M | -21.72M | -20.63M | -0.52 |
|
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
AxoGen Q4 2024 Earnings Preview - MSN
AxoGen (AXGN) Expected to Announce Earnings on Tuesday - Defense World
Objective long/short (AXGN) Report - Stock Traders Daily
Axogen, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - Nasdaq
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025 - GlobeNewswire
Axogen's Pivotal Earnings Reveal: Q4 & 2024 Performance Deep Dive Coming Soon - StockTitan
AxoGen (NASDAQ:AXGN) Hits New 52-Week HighHere's Why - MarketBeat
Calamos Advisors LLC Makes New $523,000 Investment in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Canaccord raises AxoGen stock price target to $22 from $18 By Investing.com - Investing.com Nigeria
AxoGen (NASDAQ:AXGN) Price Target Raised to $22.00 - MarketBeat
Short Interest in AxoGen, Inc. (NASDAQ:AXGN) Increases By 20.4% - MarketBeat
Axogen appoints new VP of Regulatory Affairs - MSN
PepsiCo Reports Mixed Financial Results - The Globe and Mail
AxoGen, Inc. (NASDAQ:AXGN) Shares Acquired by SG Americas Securities LLC - Defense World
AxoGen (NASDAQ:AXGN) Price Target Raised to $22.00 at Canaccord Genuity Group - Defense World
Morgan Stanley Reduces Stake in Axogen Inc: A Detailed Analysis - GuruFocus.com
Axogen Announces Appointment of Jesse Bishop as Vice - GlobeNewswire
Canaccord raises AxoGen stock price target to $22 from $18 - MSN
AxoGen appoints Jesse Bishop as VP, regulatory affairs - TipRanks
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
From Army Ranger to Biotech Executive: Special Ops Veteran Takes Helm of Axogen's Regulatory Strategy - StockTitan
Axogen stock soars to 52-week high, touches $18.99 - MSN
Cantor Fitzgerald Lowers Earnings Estimates for AxoGen - ETF Daily News
Trend Tracker for (AXGN) - Stock Traders Daily
Cantor Fitzgerald Weighs in on AxoGen FY2024 Earnings - Defense World
FY2024 EPS Estimates for AxoGen Lowered by Cantor Fitzgerald - MarketBeat
AxoGen (NASDAQ:AXGN) Reaches New 1-Year HighHere's Why - MarketBeat
Axogen stock soars to 52-week high, touches $18.99 By Investing.com - Investing.com Australia
AxoGen (NASDAQ:AXGN) Reaches New 1-Year High – Time to Buy? - Defense World
Axogen (FRA:LT3) Earnings Yield % : N/A% (As of Jan. 19, 2025) - GuruFocus.com
Axogen (FRA:LT3) 5-Year Yield-on-Cost % : 0.00 (As of Jan. 18, 2025) - GuruFocus.com
Assenagon Asset Management S.A. Sells 484,570 Shares of AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
AxoGen (NASDAQ:AXGN) Reaches New 12-Month HighShould You Buy? - MarketBeat
AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last? - MSN
AxoGen, Inc. (NASDAQ:AXGN) Shares Bought by JPMorgan Chase & Co. - Defense World
JPMorgan Chase & Co. Has $7.70 Million Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Barclays PLC Raises Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out? - MSN
Is Axogen (NASDAQ:AXGN) Using Too Much Debt? - Simply Wall St
Learn to Evaluate (AXGN) using the Charts - Stock Traders Daily
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):